Certainly! Here’s a summarized overview of four prominent Contract Development and Manufacturing Organizations (CDMOs) based on the provided information:
1. Lonza
- Location: Basel, Switzerland
- Size: Approximately 20,000 employees across 30+ sites worldwide.
- Services: Offers integrated biologics, advanced synthesis, and specialized modalities, covering early development through to drug substance and product manufacturing.
- Technologies: Mammalian biologics, small molecules, APIs, bioconjugates, mRNA, microbial products, and cell/gene therapies.
- Recent News: Expanded collaboration with a major U.S. biopharmaceutical for biologics production and appointed Samanta Cimitan as chief commercial officer.
2. Samsung Biologics
- Location: Incheon, South Korea
- Size: 5,800+ employees with 145+ global clients, biomanufacturing capacity of 845,000 liters.
- Services: End-to-end development, including drug discovery, formulation, and cGMP biologics manufacturing from clinical to commercial scales.
- Recent News: Announced a $1.8 billion offer to acquire PolyPeptide, enhancing its peptide production capabilities and a $2.2 billion rights offering for further expansion.
3. Recipharm
- Location: Stockholm, Sweden, with facilities in 8 countries.
- Size: 4,000+ employees globally.
- Services: Manufacturing of various dosage forms including sterile fill and finish, and the development of advanced therapeutics.
- Recent News: Made multimillion-dollar investments to enhance its sterile fill and finish capabilities in the U.S. and to support ophthalmic product programs.
4. Piramal Pharma Solutions
- Location: Mumbai, India, with 15 facilities globally.
- Size: 1,000-5,000 employees, part of a larger workforce exceeding 7,000 at parent company Piramal Pharma.
- Services: Drug discovery, pharmaceutical development, commercial supply of APIs, and manufacturing for biologics including vaccines and gene therapies.
- Recent News: Formed a manufacturing arrangement with Botanix Pharmaceuticals for API development and launched a new payload-linker suite in Michigan as part of a $90 million investment plan.
This concise overview captures the key details of each CDMO, including their services and recent developments.
